Associations between smoking, caffeine and NSAID make use of and Parkinson’s disease Individuals with Parkinson’s disease are less likely to smoke or consume large dosages of caffeine than their family who don’t have the disease, in the April problem of Archives of Neurology according to a written report, one of the JAMA/Archives journals. Smoking cigarettes, consuming caffeine and taking non-steroidal anti-inflammatory medications have already been reported to protect people from developing Parkinson’s disease, according to background information in this article.
Aspirin’s anti-inflammatory effects may help protect against melanoma A fresh study has discovered that women who take aspirin have a reduced risk of developing melanoma-and that the much longer they take it, the low the risk. The findings claim that aspirin's anti-inflammatory effects can help protect against this type of skin cancer. The analysis is published early on-line in CANCER, a peer-reviewed journal of the American Cancers Society. In the Women's Wellness Initiative, experts observed US women aged 50 to 79 years for an average of 12 years and noted which individuals developed cancers. At the beginning of the study, the ladies were asked which medications they required, what they ate, and what activities they performed. Related StoriesImlygic accepted for treatment of melanoma lesions in the skin and lymph nodesUCSF-led researchers map out melanoma's genetic trajectoriesNew Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours When Jean Tang MD, PhD, of Stanford University College of Medicine in Palo Alto, and her colleagues analyzed available data from 59,806 Caucasian ladies in the study, they found that ladies who took more aspirin were less likely to develop melanoma pores and skin cancer through the 12 years of follow-up.